Emergent BioSolutions (EBS) Debt Ratio (2010 - 2026)
Emergent BioSolutions' Debt Ratio came in at 0.52 for Q2 2026, up 10.5% from 0.47 a year earlier and up 19.9% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Debt Ratio (2010 - 2026) Analysis & Trends
For FY2025, Emergent BioSolutions' Debt Ratio was 0.43, down 9.2% from FY2024.
- Going back by year, Debt Ratio was 0.48 in FY2024 (+1.2%), 0.47 in FY2023 (+6.3%), 0.44 in FY2022 (+56.1%) and 0.28 in FY2021 (-6.3%).
- The Q2 2026 figure represents the highest quarterly Debt Ratio since Q2 2024.
- Year-over-year, Debt Ratio increased in three of the last eight quarters, with an average decline of 3.6%.
- The fastest year-over-year change in Debt Ratio over five years came in Q1 2023 (growth of 58.2%), and the weakest in Q2 2025 (a decline of 17.3%).
- Business Quant data shows EBS's Debt Ratio at 0.43 (Q1 2026), 0.43 (Q4 2025) and 0.45 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,148.30 Bn | 1,116.89 Bn | 19.71 Bn | 0.39 |
| 2 | Johnson & Johnson | 624.42 Bn | 542.95 Bn | 17.26 Bn | 0.24 |
| 3 | AbbVie | 509.35 Bn | 482.46 Bn | 12.70 Bn | 0.52 |
| 4 | Merck | 366.08 Bn | 320.46 Bn | 12.21 Bn | 0.42 |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 0.08 |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 0.28 |
| 7 | Amgen | 236.09 Bn | 191.49 Bn | 7.24 Bn | 0.60 |
| 8 | Gilead Sciences | 194.04 Bn | 168.24 Bn | 6.22 Bn | 0.53 |
| 9 | Pfizer | 171.91 Bn | 118.56 Bn | 10.94 Bn | 0.31 |
| 10 | Emergent BioSolutions | 322.50 Mn | -428.40 Mn | 137.20 Mn | 0.52 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.52 |
| Mar 31, 2026 | 0.43 |
| Dec 31, 2025 | 0.43 |
| Sep 30, 2025 | 0.45 |
| Jun 30, 2025 | 0.47 |
| Mar 31, 2025 | 0.47 |
| Dec 31, 2024 | 0.48 |
| Sep 30, 2024 | 0.45 |
| Jun 30, 2024 | 0.57 |
| Mar 31, 2024 | 0.50 |
| Dec 31, 2023 | 0.47 |
| Sep 30, 2023 | 0.46 |
| Jun 30, 2023 | 0.41 |
| Mar 31, 2023 | 0.47 |
| Dec 31, 2022 | 0.44 |
| Sep 30, 2022 | 0.36 |
| Jun 30, 2022 | 0.30 |
| Mar 31, 2022 | 0.30 |
| Dec 31, 2021 | 0.28 |
| Sep 30, 2021 | 0.30 |
API Access
Emergent BioSolutions Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();